Massachusetts Justice Community Opioid Innovation Network (MassJCOIN)
The goal of this study is to conduct a Type 1 hybrid effectiveness-implementation study of seven jails in Massachusetts that deliver all FDA-approved MOUDs (naltrexone, buprenorphine, methadone) to produce findings with implications for policies for OUD in criminal justice settings….
Medication Access in Prisons and Jails: Some Answers, More Questions
Introduction and commentary regarding research, policy, and barriers to the use of MOUD in carceral settings.
Medication-Assisted Treatment in Problem-solving Courts: A National Survey of State and Local Court Coordinators
This paper reports on a national survey of PSCs (N = 42 state-wide court coordinators; N = 849 local court coordinators) and examines the structural factors that could explain the likelihood of a local PSC authorizing medication-assisted treatment (MAT) and…
Modeling the impact of spatial inequities in access to medications for treatment of opioid use disorder among persons who inject drugs
Actual (real-world) and counterfactual scenarios of varying levels of social and spatial inequity to providers of methadone were evaluated using HepCEP, a validated agent-based model of syringe sharing behaviors among people who inject drugs (PWID) in metropolitan Chicago, Illinois, U.S.A….
National variability in Americans’ COVID-19 protective behaviors
Protective behaviors such as mask wearing and physical distancing are critical to slow the spread of COVID-19, even in the context of vaccine scale-up. Understanding the variation in self-reported COVID-19 protective behaviors is critical to developing public health messaging. The…